Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited ... manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and ...

2000 -The Ahmedabad-based Cadila Healthcare of the Zydus group and the Baroda-based ... has been changed from Sarabhai Campus Gorwa Road,Vadodara -390023 To Shanti sadan Mirzapur Road Ahmedabad ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Zydus Lifesciences has introduced ANVIMO, a breakthrough medication for preventing Cytomegalovirus (CMV) infection in haematopoietic stem cell and kidney transplant patients. The drug, containing ...

Zydus Lifesciences announced today it will develop the world’s first combination vaccine targeting both typhoid fever and shigellosis, with financial backing from the Bill & Melinda Gates ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

(Image Credits: Pixabay) Zydus on Wednesday said that a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients.

Discover how Zydus Wellness is reinventing Complan, the iconic health drink, by expanding its target audience, leveraging digital commerce, and strengthening its scientific credibility to stay ...

Zydus will carry out early-stage development. (Image Credits: Pixabay) Zydus Lifesciences Limited on Tuesday announced its focus on the development of a combination vaccine against shigellosis and ...

Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...

and Zydus Lifesciences hit their 52-week lows in intraday trade on BSE on Wednesday, February 19, on the backdrop of conflicting global signals and uncertainties regarding the US tariffs that were ...